Caleb Kil
Medical · la Palma, CANPI 1699319848
Payments from drug & device makers
Across 353 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$845
- Novo Nordisk$732
- AbbVie$639
- Novartis$548
- AstraZeneca$470
- Lilly USA, LLC$387
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,29599%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 48 | $845 |
| Novo Nordisk | 69 | $732 |
| AbbVie | 27 | $639 |
| Novartis | 36 | $548 |
| AstraZeneca | 15 | $470 |
| Lilly USA, LLC | 26 | $387 |
| Pfizer | 22 | $357 |
| Bayer | 11 | $350 |
| Merck | 12 | $232 |
| Boehringer Ingelheim | 13 | $206 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $192 |
| Radius Health, Inc. | 8 | $149 |
| Sanofi | 1 | $130 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $129 |
| GSK | 7 | $127 |
| Ardelyx, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $111 |
| Dexcom, Inc. | 1 | $101 |
| Sanofi Pasteur Inc. | 4 | $82 |
| Idorsia Pharmaceuticals US Inc | 5 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Abiomed | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Exeltis, USA Inc. | 1 | $24 |
| Biogen | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Optinose US, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
| Organon | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$150
- DUPIXENT$130
- IBSRELA$125
- BREZTRI$125
- AIRSUPRA$125
- Wegovy$122
- VRAYLAR$121
- UBRELVY$105
- DEXCOM G7 GSS (161)$101
- DEXCOM STELO GLUCOSE BIOSENSOR$101
How this compares
$6,390 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 44 | $46,663 |
| OzempicSemaglutide | 39 | $40,593 |
| RybelsusSemaglutide | 15 | $29,432 |
| MounjaroTirzepatide | 19 | $19,107 |
| ProliaDenosumab | 11 | $18,423 |
| TrulicityDulaglutide | 13 | $13,988 |
| EntrestoSacubitril/Valsartan | 13 | $11,169 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,532 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $9,593 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $1,401 |
| Atorvastatin Calcium | 102 | $1,258 |
| Pregabalin | 15 | $1,121 |
| Levocetirizine Dihydrochloride | 43 | $808 |
| Valsartan | 30 | $801 |
| Celecoxib | 36 | $750 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $732 | $70,02554 claims |
| Boehringer IngelheimJardiance | $206 | $46,66344 claims |
| Lilly USA, LLCMounjaro, Trulicity | $387 | $33,09632 claims |
| AmgenProlia | $845 | $18,42311 claims |
| NovartisEntresto | $548 | $11,16913 claims |
| GSKTrelegy Ellipta | $127 | $10,53217 claims |
| AstraZenecaBreztri Aerosphere | $470 | $9,59313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in la Palma
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.